Brief: Shivalik Rasayan Issued LOA To Medicamen Biotech
19/07/2023 07:34
July 19 (Reuters) - Shivalik Rasayan Ltd SIVA.NS :
* ISSUED LOA TO MEDICAMEN BIOTECH, TO USE DMF GRADE
BORTEZOMIB API
FOR FORMULATION OF BORTEZOMIB INJECTION 3.5MG/ VIAL
Source text for Eikon: ID:nBSE219bhg
Further company coverage: SIVA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shivalik Rasayan
See all newsBrief: Shivalik Rasayan Ltd March-Quarter Consol Net Profit 45.3 Million Rupees
Brief: Shivalik Rasayan Says US FDA Approved API Facility At Dahej
India's Shivalik Rasayan climbs on US FDA approval for facility
India's Shivalik Rasayan up as U.S. FDA completes inspection at Gujarat factory
Brief: Shivalik Rasayan Says US FDA Completes Inspection At API Facility At Dahej Unit